Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
J Vet Med Sci ; 66(4): 357-65, 2004 Apr.
Article in English | MEDLINE | ID: mdl-15133264

ABSTRACT

Nitric oxide (NO*) synthesis is induced within many tumors. The timecourse of NO* synthesis was evaluated during intraperitoneal Meth A fibrosarcoma progression. While increasing macrophage recruitment into ascites was noted, inducible nitric oxide synthase (iNOS) antigen and function peaked between days 3-6 after tumor implantation. The capacity of cells to respond to LPS and IFNgamma stimulation was markedly depressed on day 9 and 11. Cellular proliferation correlated in an inverse fashion with levels of NO* synthesis. Electron paramagnetic resonance spectroscopy and nitrotyrosine immunostaining failed to show accumulation of characteristic target cell lesions induced by NO*. These findings lead us to conclude that NO* production was increasingly suppressed during Meth A tumor progression. Depression of NO* production did not correlate with levels of the inhibitory cytokines TGFbeta and IL-10, but could be partially overcome by addition of sepiapterin (a tetrahydrobiopterin prodrug). Thus, depletion of essential co-factors necessary for iNOS function may contribute to depressed NO* responses during cancer progression.


Subject(s)
Ascites/metabolism , Cytokines/metabolism , Fibrosarcoma/metabolism , Macrophages/metabolism , Nitric Oxide/biosynthesis , Animals , Ascites/pathology , Fibrosarcoma/immunology , Flow Cytometry , Fluorescent Antibody Technique , Immunohistochemistry , Macrophages/immunology , Mice , Mice, Inbred BALB C , Nitric Oxide/immunology , Nitric Oxide Synthase/antagonists & inhibitors , Nitric Oxide Synthase Type II , Spectrum Analysis , Time Factors
2.
J Vet Med Sci ; 66(5): 357-65, 2004 May.
Article in English | MEDLINE | ID: mdl-15198099

ABSTRACT

Nitric oxide (NO*) synthesis is induced within many tumors. The time course of NO* synthesis was evaluated during intra-peritoneal Meth A fibrosarcoma progression. While increasing macrophage recruitment into ascites was noted, inducible nitric oxide synthase (iNOS) antigen and function peaked between days 3-6 after tumor implantation. The capacity of cells to respond to LPS and IFNgamma stimulation was markedly depressed on day 9 and 11. Cellular proliferation correlated in an inverse fashion with levels of NO* synthesis. Electron paramagnetic resonance spectroscopy and nitrotyrosine immunostaining failed to show accumulation of characteristic target cell lesions induced by NO*. These findings lead us to conclude that NO* production was increasingly suppressed during Meth A tumor progression. Depression of NO* production did not correlate with levels of the inhibitory cytokines TGFbeta and IL-10, but could be partially overcome by addition of sepiapterin (a tetrahydrobiopterin prodrug). Thus, depletion of essential co-factors necessary for iNOS function may contribute to depressed NO* responses during cancer progression.


Subject(s)
Ascites/metabolism , Cytokines/metabolism , Fibrosarcoma/metabolism , Nitric Oxide/biosynthesis , Phagocytes/metabolism , Animals , Cell Line, Tumor , Disease Models, Animal , Electron Spin Resonance Spectroscopy , Enzyme Repression/drug effects , Immunohistochemistry , Lipopolysaccharides/metabolism , Mice , Mice, Inbred BALB C , Nitric Oxide Synthase/antagonists & inhibitors , Nitric Oxide Synthase/metabolism , Nitric Oxide Synthase Type II , Nitrites/metabolism , Pterins/pharmacology , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL